Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

38 trials with published results (18%)

Research Maturity

123 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.4%

18 terminated out of 215 trials

Success Rate

87.2%

+0.7% vs benchmark

Late-Stage Pipeline

7%

16 trials in Phase 3/4

Results Transparency

31%

38 of 123 completed with results

Key Signals

38 with results87% success18 terminated

Data Visualizations

Phase Distribution

168Total
Not Applicable (112)
Early P 1 (4)
P 1 (25)
P 2 (11)
P 3 (10)
P 4 (6)

Trial Status

Completed123
Unknown29
Terminated18
Recruiting17
Not Yet Recruiting10
Active Not Recruiting8

Trial Success Rate

87.2%

Benchmark: 86.5%

Based on 123 completed trials

Clinical Trials (215)

Showing 20 of 20 trials
NCT01786317Not ApplicableCompletedPrimary

Anal Motor Function in Fecal Incontinence

NCT07499258Not Yet RecruitingPrimary

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

NCT07524439Phase 1Not Yet RecruitingPrimary

Use of a β-Glucan Cream in Incontinence-Associated Dermatitis

NCT05708612Not ApplicableActive Not RecruitingPrimary

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

NCT05776277Phase 3Active Not RecruitingPrimary

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

NCT05200923Not ApplicableRecruiting

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

NCT05396456Not ApplicableRecruitingPrimary

Autologous Muscle Fiber Fragment Injections

NCT03811821Not ApplicableActive Not RecruitingPrimary

Fecal Incontinence Treatment (FIT) Study

NCT05773742Not ApplicableActive Not Recruiting

Treatment of Fecal Incontinence and Chronic Constipation With Low-volume Irrigation

NCT06091566Not ApplicableRecruiting

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

NCT02414425Phase 3CompletedPrimary

Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence

NCT05998187Phase 3RecruitingPrimary

Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections

NCT07313085Not Yet Recruiting

Mechanisms of Fecal Incontinence in Wolfram Syndrome

NCT03317938Not ApplicableCompletedPrimary

Studies in Patients With Defecatory Disorders

NCT05626816Not ApplicableRecruitingPrimary

Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury

NCT06330857Not ApplicableCompleted

Recurrence and Bowel Function After Laparoscopic Vaginorectopexy, a Modified Anterior Rectopexy

NCT01632839Completed

Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality

NCT06152224Phase 4Active Not RecruitingPrimary

Use of the LEVA® Pelvic Health System for Fecal Incontinence

NCT06532123Not ApplicableRecruitingPrimary

Mechanisms of Improving Fecal Continence Muscles Motor Function

NCT05412069Not ApplicableRecruiting

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Scroll to load more

Research Network

Activity Timeline